Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Disallow: /cloud Disallow: |
Title | Startseite - |
Description | March 2022: Research and Medical Chemicals Group reinforces management Share Print Suchbegriff English Deutsch Home Contact Imprint Synthesis Analytics Isolation Company Partner Jobs Contact Download Online Shop Reagenzglas B |
Keywords | N/A |
WebSite | reseachem.ch |
Host IP | 192.162.28.20 |
Location | Switzerland |
Site | Rank |
US$401,311
Last updated: 2023-05-17 10:10:04
reseachem.ch has Semrush global rank of 26,374,326. reseachem.ch has an estimated worth of US$ 401,311, based on its estimated Ads revenue. reseachem.ch receives approximately 46,306 unique visitors each day. Its web server is located in Switzerland, with IP address 192.162.28.20. According to SiteAdvisor, reseachem.ch is safe to visit. |
Purchase/Sale Value | US$401,311 |
Daily Ads Revenue | US$371 |
Monthly Ads Revenue | US$11,114 |
Yearly Ads Revenue | US$133,359 |
Daily Unique Visitors | 3,088 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
reseachem.ch. | A | 599 | IP: 192.162.28.20 |
reseachem.ch. | NS | 600 | NS Record: dns11.webstyle.ch. |
reseachem.ch. | NS | 600 | NS Record: dns10.webstyle.ch. |
reseachem.ch. | MX | 600 | MX Record: 20 2.antispam.mbbsolutions.ch. |
reseachem.ch. | MX | 600 | MX Record: 10 1.antispam.mbbsolutions.ch. |
reseachem.ch. | MX | 600 | MX Record: 5 3.antispam.mbbsolutions.ch. |
reseachem.ch. | TXT | 600 | TXT Record: v=spf1 +a +mx include:spf.webstyle.ch ip4:194.126.200.0/24 ip4:149.126.0.0/21 ip4:62.12.149.245 include:nl2go.com -all |
reseachem.ch. | TXT | 600 | TXT Record: google-site-verification=MZV5B7QWviX3-AHxSPBcuPssfwFMT5sMNtA2cRMcgS4 |
Share Print Suchbegriff English Deutsch Home Contact Imprint Synthesis Analytics Isolation Company Partner Jobs Contact Download Online Shop Reagenzglas Bio NMR Clinical Research Strukturformel Metabolic Reagenzglas Bio NMR Clinical Research Strukturformel Metabolic March 2022: Research and Medical Chemicals Group reinforces management structure Nico Aelmans (Group CEO) is pleased to announce that in order to cater for growth Research and Medical Chemicals Group (RMC) of which Buchem BV is an integral part has reinforced the management structure by following nominations as per 1st February 2022. Johan Leugs will assume the responsibility of Chief Operating Officer Luc Amkreutz has been appointed Chief Financial Officer Casper (John) Frijns will support the group as Chief Marketing and Sales Officer With these appointments RMC will be able to further drive the integration of Buchem’s sister companies ReseaChem GmbH and Swant AG as well as preparing the ground for further acquisitions. |
HTTP/1.1 301 Moved Permanently Server: nginx Date: Sat, 19 Mar 2022 09:25:39 GMT Content-Type: text/html Content-Length: 162 Connection: keep-alive Location: https://reseachem.ch/ HTTP/2 200 server: nginx date: Sat, 19 Mar 2022 09:25:40 GMT content-type: text/html; charset=UTF-8 vary: Accept-Encoding x-powered-by: PHP/7.4.28 expires: Thu, 19 Nov 1981 08:52:00 GMT cache-control: no-store, no-cache, must-revalidate pragma: no-cache set-cookie: WSESSIONID=p552d9ceo8ns9v0302cejnosuj; path=/; secure; HttpOnly; SameSite=Lax x-powered-by: PleskLin |